Clinical Trial Update: A Study of Alvimopan for the Management of Postoperative Ileus in Participants Undergoing Radical Cystectomy [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update evaluating alvimopan for the management of postoperative ileus in participants undergoing radical cystectomy; results have been po…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Postoperative Ileus

Drugs mentioned

• Alvimopan (alvimopan)

Snippet

Sponsor: Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) | Conditions: Postoperative Ileus | Phase 4 | Status: COMPLETED | Results posted: 2015-07-02